Latest Post | Last 10 Posts | Archives
Previous Post: Open thread
Next Post: Sen. Robert Peters launches bid to succeed Robin Kelly
Posted in:
[The following is a paid advertisement.]
Southern Illinois Healthcare (SIH) serves a 16-county rural area that’s considered medically underserved and, in some counties, over 20% of residents live in poverty. The federal 340B drug discount program has been a lifeline for hospitals that are often the sole providers of care in communities with high poverty levels. Savings from the 340B program have helped SIH meet the healthcare needs of underserved southern Illinois communities.
Because of 340B, SIH has been able to promote health and well-being by expanding access to care and providing additional services, including cancer care and infusion services; chronic disease and diabetes self-management programs; and behavioral health support and services.
Yet, recent barriers by pharmaceutical companies are limiting access to drug savings that hospitals use to invest in patients. Such roadblocks include limiting contract pharmacy relationships to one per covered entity, radius requirements, claims share/data requirements and National Drug Code restrictions.
“These constraints amount to over $2 million annually which could have gone to patients,” said SIH Chief Financial Officer Warren Ladner. “The negative impact of the manufacturer restrictions includes medication adherence issues (missed doses, delays) and impact continuity of care, resulting in readmissions and an overall increase in our health system’s total cost of care.”
Vote YES Senate Bill 2385 and House Bill 3350 to preserve the intent of the 340B program. Learn more.
posted by Advertising Department
Tuesday, May 13, 25 @ 8:40 am
Sorry, comments are closed at this time.
Previous Post: Open thread
Next Post: Sen. Robert Peters launches bid to succeed Robin Kelly
WordPress Mobile Edition available at alexking.org.
powered by WordPress.